carbostyril has been researched along with Sinusitis in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (43.75) | 18.2507 |
| 2000's | 1 (6.25) | 29.6817 |
| 2010's | 4 (25.00) | 24.3611 |
| 2020's | 4 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Branstetter, BF; Goralski, JL; Kimple, AJ; Lee, SE; Nouraie, SM; Pilewski, JM; Senior, BA; Shaffer, AD; Stapleton, AL; Zemke, AC | 1 |
| Goda, K; Hashimoto, H; Hatakeyama, S; Kitsuregawa, M; Mitsutake, N; Nagai, R; Saito, M; Sato, J | 1 |
| Allen, M; Cho, DY; Elder, JB; Grayson, JW; Lim, DJ; McCormick, J; McLemore, JG; Rowe, SM; Skinner, D; West, JM; Woodworth, BA; Zhang, S | 1 |
| Antonelli, PJ; Hincapie-Castillo, JM; Tran, PT; Winterstein, AG | 1 |
| Alexander, DK; Cho, DY; Grayson, JW; Hill, HS; Lim, DJ; Mackey, C; Peña Garcia, JA; Skinner, D; Weeks, CG; Woodworth, BA; Zhang, S | 1 |
| Cho, DY; Hathorne, H; Lampkin, B; McCormick, J; Richman, J; Rowe, SM; Woodworth, BA | 1 |
| Adriaenssens, N; Bartholomeeusen, S; Coenen, S; Ryckebosch, P | 1 |
| Abou Alaiwa, MH; Chang, EH; Ernst, SE; Graham, SM; Hilkin, B; Hornick, DB; Karp, PH; Launspach, JL; Shah, VS; Stoltz, DA; Tang, XX; Welsh, MJ; Zabner, J | 1 |
| Citron, DM; Fernandez, HT; Goldstein, EJ; Merriam, CV; Tyrrell, KL; Warren, YA | 1 |
| Berche, P; Gaillot, O | 1 |
| Berche, P; Gehanno, P | 1 |
| Chuck, SK; Jung, R; Martin, SJ; Messick, CR; Meyer, JM; Pendland, SL | 1 |
| Dorr, MB; Lipsky, BA; Magner, DJ; Talbot, GH | 1 |
| Gehanno, P; Trémolières, F | 1 |
| El'kun, GB | 1 |
| Nakano, Y; Nonomura, N | 1 |
1 review(s) available for carbostyril and Sinusitis
| Article | Year |
|---|---|
Levofloxacin and sparfloxacin: new quinolone antibiotics.
Topics: Absorption; Anti-Infective Agents; Bronchitis; Drug Interactions; Drug Resistance, Microbial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Ofloxacin; Pneumonia; Quinolones; Sinusitis; Skin Diseases; Urinary Tract Infections | 1998 |
2 trial(s) available for carbostyril and Sinusitis
| Article | Year |
|---|---|
Sparfloxacin versus cefuroxime axetil in the treatment of acute purulent sinusitis. Sinusitis Study Group.
Topics: Acute Disease; Adult; Anti-Infective Agents; Cefuroxime; Cephalosporins; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Prodrugs; Quinolones; Sinusitis | 1996 |
[Effectiveness of maxaquin and tarivid in combined therapy of patients with chronic sinusitis].
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Antitubercular Agents; Chronic Disease; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Male; Middle Aged; Ofloxacin; Quinolones; Sinusitis; Treatment Outcome | 1999 |
13 other study(ies) available for carbostyril and Sinusitis
| Article | Year |
|---|---|
Elexacaftor-Tezacaftor- Ivacaftor improves sinonasal outcomes in cystic fibrosis.
Topics: Adolescent; Adult; Aminophenols; Benzodioxoles; Child; Chloride Channel Agonists; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Indoles; Middle Aged; Mutation; Pyrazoles; Pyridines; Pyrrolidines; Quinolones; Sinusitis; Young Adult | 2022 |
Indications and classes of outpatient antibiotic prescriptions in Japan: A descriptive study using the national database of electronic health insurance claims, 2012-2015.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antimicrobial Stewardship; Cephalosporins; Child; Child, Preschool; Communicable Diseases; Databases, Factual; Drug Prescriptions; Female; Humans; Infant; Infant, Newborn; Insurance, Health; Japan; Macrolides; Male; Middle Aged; Outpatients; Pharyngitis; Quinolones; Respiratory Tract Infections; Sinusitis; Young Adult | 2020 |
Controlled delivery of ciprofloxacin and ivacaftor via sinus stent in a preclinical model of Pseudomonas sinusitis.
Topics: Aminophenols; Animals; Chronic Disease; Ciprofloxacin; Maxillary Sinus; Pseudomonas; Pseudomonas Infections; Quinolones; Rabbits; Sinusitis; Stents | 2020 |
Association of US Food and Drug Administration Removal of Indications for Use of Oral Quinolones With Prescribing Trends.
Topics: Anti-Bacterial Agents; Drug Prescriptions; Humans; Interrupted Time Series Analysis; Practice Patterns, Physicians'; Pulmonary Disease, Chronic Obstructive; Quinolones; Sinusitis; United States; United States Food and Drug Administration; Urinary Tract Infections | 2021 |
l-Methionine anti-biofilm activity against Pseudomonas aeruginosa is enhanced by the cystic fibrosis transmembrane conductance regulator potentiator, ivacaftor.
Topics: Aminophenols; Anti-Bacterial Agents; Biofilms; Chronic Disease; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Progression; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Humans; Methionine; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Rhinitis; Sinusitis | 2018 |
Ivacaftor improves rhinologic, psychologic, and sleep-related quality of life in G551D cystic fibrosis patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminophenols; Child; Chronic Disease; Cohort Studies; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Female; Humans; Male; Mental Health; Middle Aged; Mutation; Prospective Studies; Quality of Life; Quinolones; Rhinitis; Sinusitis; Sleep; Surveys and Questionnaires; Young Adult | 2019 |
Quality of antibiotic prescription during office hours and out-of-hours in Flemish primary care, using European quality indicators.
Topics: Adolescent; Adult; After-Hours Care; Aged; Anti-Bacterial Agents; Bronchitis; Child; Child, Preschool; Cystitis; Databases, Factual; Drug Prescriptions; Female; Guideline Adherence; Humans; Infant; Middle Aged; Netherlands; Otitis Media; Pneumonia, Bacterial; Practice Guidelines as Topic; Primary Health Care; Quality Indicators, Health Care; Quinolones; Sinusitis; Tonsillitis; Young Adult | 2014 |
Medical reversal of chronic sinusitis in a cystic fibrosis patient with ivacaftor.
Topics: Aminophenols; Anti-Inflammatory Agents; Cells, Cultured; Child; Chronic Disease; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Female; Humans; Hydrogen-Ion Concentration; Ion Transport; Mutation; Quinolones; Respiratory Mucosa; Sinusitis; Treatment Outcome; Viscosity | 2015 |
In vitro activities of ABT-492, a new fluoroquinolone, against 155 aerobic and 171 anaerobic pathogens isolated from antral sinus puncture specimens from patients with sinusitis.
Topics: Anti-Infective Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Paranasal Sinuses; Quinolones; Sinusitis | 2003 |
In vitro susceptibility to ciprofloxacin of bacterial strains isolated from chronic otitis media and chronic sinusitis.
Topics: Adult; Anti-Infective Agents; Bacteria; Chronic Disease; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Ofloxacin; Otitis Media; Quinolones; Sinusitis | 1995 |
Safety profile of sparfloxacin, a new fluoroquinolone antibiotic.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Bronchitis; Clinical Trials, Phase III as Topic; Community-Acquired Infections; Data Interpretation, Statistical; Female; Fluoroquinolones; Heart Rate; Humans; Male; Middle Aged; Photosensitivity Disorders; Pneumonia, Bacterial; Quinolones; Sinusitis; Skin Diseases, Bacterial | 1999 |
[New fluoroquinolones and treatment of acute sinusitis].
Topics: Acute Disease; Anti-Infective Agents; Drug Resistance, Microbial; Gram-Positive Bacteria; Humans; Quinolones; Sinusitis | 1999 |
[Infectious diseases in otolaryngology].
Topics: Acute Disease; Anti-Bacterial Agents; Bacteria; Cephalosporins; Drug Therapy, Combination; Humans; Laryngitis; Otitis Media; Penicillins; Quinolones; Sinusitis; Tetracyclines; Tonsillitis | 1990 |